Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance

This article summarizes the current landscape of treatment in EGFR-mutated lung cancer and discusses the different resistance mechanisms. It gives a  perspective on novel EGFR TKIs and potential combination strategies to overcome resistance.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research